Clark Capital Management Group, Inc. Dexcom Inc Transaction History

Clark Capital Management Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $568,648 - $724,019	-5,155 Reduced 31.27%	11,332 $1.28 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $621,927 - $762,844	5,445 Added 49.31%	16,487 $2.29 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $833,560 - $1.37 Million	11,042 New	11,042 $1.37 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Clark Capital Management Group, Inc. with notifications on news.